- Feed Grade
- Pharmaceutical Grade
- Evonik (Germany)
- GENDONE (China)
- HebeiDaxiao (China)
- TianchengChempharm (China)
- Lubon Industry (China)
- Hubei Yuanhua (China)
- Jiangsu Yuanyang (China)
- Shijiazhuang Zexing (China)
-
North America
- U.S.A.
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
- Market Forecast for 2017-24
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current Market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End-user/application Analysis
- Market Forecast for 2024-2030
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End user/application Analysis
Guanidinoacetic Acid Market Analysis & Forecast 2024-2030
Guanidinoacetic Acid Market By Product Type (Feed Grade, Pharmaceutical Grade) By Application / End User (Fodder, Medicine) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)
Guanidinoacetic acid (GAA) or Glycocyamine is the biochemical precursor of creatine, which is phosphorylated. It plays an important role as a high-energy carrier in the muscle. Glycocyamine is actually a metabolite of glycine in which the amino group has been converted into a guanidine.Guanidinoacetic acid can be used to increase muscle strength and to reduce muscle fatigue. And add guanidinoacetic acid into fodder can make lean pig's body improve significantly. GAA might be considered as an innovative way to improve exercise performance.It has recently been suggested as a possible alternative to creatine to tackle brain creatine levels in experimental medicine. Due to upgraded bioavailability and convenient utilization of the compound, taking GAA orally might be benefitial for AGAT patients. But it has several drawbacks like brain methylation issues, neurotoxicity, and hyperhomocysteinemia.
From studies it has been observed that a combination of betaine and glycocyamine improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine provides methyl group to glycocyamine, via methionine, for the formation of creatine. Because of this, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. It is also useful for the patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure for improving cardiac function. It is also helpful in gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido. People suffering from hypertension experienced transient reduced blood pressure.It also increase of glucose tolerance in both diabetic and without diabetes subjects.
Geogrphically, Guanidinoacetic Acid Market analysis covers regions- North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
Guanidinoacetic Acid Market : By Product Type
Global Guanidinoacetic Acid Market: Companies Covered
Geographical analysis of Guanidinoacetic Acid Market includes :
Guanidinoacetic Acid Market Report delivers a comprehensive analysis of the following parameters :
Global Guanidinoacetic Acid Market Report delivers a comprehensive analysis of the following parameters:
Report Coverage
| Parameters | Details |
|---|---|
Base Year |
2023 |
|
Historical Data |
2018-2023 |
|
Forecast Data |
2024-2030 |
|
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Frequently Asked Questions (FAQ)
Guanidinoacetic Acid Market report considers 2021 as the base year.
Guanidinoacetic Acid Market report considers data for period 2016 to 2021 as the historical data to predict market forecast between 2022 to 2029.
Yes, report is inclusive in-detailed analysis of key players in Guanidinoacetic Acid Market
Guanidinoacetic Acid Market Study is broadly divided into North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW. Also these regions are further analysed as per various countries
Guanidinoacetic Acid Market Report includes Market Segmentation, Regional outlook, Application Analysis, Competitive analysis, Supply-Demand Analysis, Pricing insight.
Yes, the report includes COVID 19 impact on the market.
Inquire Before Buying
We are committed to offering 100 % free customization while purchasing.
Receive a detailed insight into the Guanidinoacetic Acid Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.
Request Free Sample